A cost-effectiveness analysis of pharmacotherapy versus prostatic urethral lift as initial therapy for patients with moderate benign prostatic hyperplasia.
Expert review of pharmacoeconomics & outcomes research（2023）
摘要
Prostatic urethral lift is a cost-effective initial treatment option for men with moderate symptoms of benign prostatic hyperplasia.
更多查看译文
关键词
Benign prostatic hyperplasia,cost-effectiveness,minimally invasive,prostatic urethral lift
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要